Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2007-11-06
2007-11-06
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S345000, C514S568000, C546S301000, C546S342000, C562S426000, C562S465000
Reissue Patent
active
11288022
ABSTRACT:
This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds of their salts, and methods of using them as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes in a mammal as well as methods of suppressing appetite and modulating leptin levels in a mammal. The present invention also discloses methods for making the disclosed compounds.
REFERENCES:
patent: 5447656 (1995-09-01), Jungbauer et al.
patent: 6506757 (2003-01-01), Tajima et al.
patent: 2003/0207915 (2003-11-01), Cheng et al.
patent: 2003/0207916 (2003-11-01), Cheng et al.
patent: 2003/0207924 (2003-11-01), Cheng et al.
patent: 3526235 (1986-05-01), None
patent: 4002374 (1991-08-01), None
patent: 0578054 (1994-01-01), None
patent: 0930299 (1994-07-01), None
patent: 0625513 (1994-11-01), None
patent: 09194418 (1997-07-01), None
patent: WO96/04228 (1996-02-01), None
patent: WO97/28137 (1997-08-01), None
patent: WO 97/28149 (1997-08-01), None
patent: WO99/46232 (1999-09-01), None
patent: WO 01/00603 (2001-01-01), None
patent: WO 01/16120 (2001-03-01), None
patent: WO02/50048 (2002-06-01), None
patent: WO02/062774 (2002-08-01), None
patent: WO 02/092590 (2002-11-01), None
patent: WO 02/100403 (2002-12-01), None
patent: WO 03/024395 (2003-03-01), None
Nishimura, Koji: “Preparation of Indole Derivatives as Chymase Inhibitors and Drugs containing the same as the active Ingredient” XP002258311.
Nanteuil De G et al.: “5-Imidaol-yl-1H Benzimidazoles Inhibiteurs De L Interleukine-l: Une Nouevlle Voie Pour Le Traitement De L' Arthrose” XP001147539.
U.S. Appl. No. 10/774,260, filed Feb. 6, 2004.
T. Gordon et al., The American Journal of Medicine, 1977;62:707-714.
Rissanen et al., British Medical Journal,301:835-837 (1990).
W.R. Oliver et al., PNAS, vol. 98, pp. 5306-5311, (2001).
S.M. Berge et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences, 1977:66:1-19.
Belleney, J. et al., Heterocyclic Chem., 1984;21:1431.
Auerbach Bruce J.
Bratton Larry D.
Filzen Gary
Geyer Andrew G.
Trivedi Bharat K.
Ashbrook Charles W.
Davis Zinna N.
Gammill Martha
Sherwood Michelle
Warner & Lambert Company
LandOfFree
Compounds that modulate PPAR activity and methods for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that modulate PPAR activity and methods for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that modulate PPAR activity and methods for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862873